{"disease":{"id":"congenital-fibrinogen-deficiency","name":"congenital fibrinogen deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02427217","title":"An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT03793426","title":"Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency","phase":"","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Octapharma","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}